DCGI Cuts Drug Approval Timelines Below 150 Days
India's DCGI has reduced drug approval timelines by over 50%, with marketing authorizations now granted in under 150 days and clinical trial approvals in 120, 135 days. The regulator has also removed mandatory prior approval at the pre-clinical stage, lowering barriers for early drug development. Both changes are in eff